181 related articles for article (PubMed ID: 38401911)
1. Precision Oncology in Breast Cancer Surgery.
Abbasi AB; Wu V; Lang JE; Esserman LJ
Surg Oncol Clin N Am; 2024 Apr; 33(2):293-310. PubMed ID: 38401911
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer subtypes: morphologic and biologic characterization.
Masood S
Womens Health (Lond); 2016 Jan; 12(1):103-19. PubMed ID: 26756229
[TBL] [Abstract][Full Text] [Related]
3. Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial.
; Yee D; DeMichele AM; Yau C; Isaacs C; Symmans WF; Albain KS; Chen YY; Krings G; Wei S; Harada S; Datnow B; Fadare O; Klein M; Pambuccian S; Chen B; Adamson K; Sams S; Mhawech-Fauceglia P; Magliocco A; Feldman M; Rendi M; Sattar H; Zeck J; Ocal IT; Tawfik O; LeBeau LG; Sahoo S; Vinh T; Chien AJ; Forero-Torres A; Stringer-Reasor E; Wallace AM; Pusztai L; Boughey JC; Ellis ED; Elias AD; Lu J; Lang JE; Han HS; Clark AS; Nanda R; Northfelt DW; Khan QJ; Viscusi RK; Euhus DM; Edmiston KK; Chui SY; Kemmer K; Park JW; Liu MC; Olopade O; Leyland-Jones B; Tripathy D; Moulder SL; Rugo HS; Schwab R; Lo S; Helsten T; Beckwith H; Haugen P; Hylton NM; Van't Veer LJ; Perlmutter J; Melisko ME; Wilson A; Peterson G; Asare AL; Buxton MB; Paoloni M; Clennell JL; Hirst GL; Singhrao R; Steeg K; Matthews JB; Asare SM; Sanil A; Berry SM; Esserman LJ; Berry DA
JAMA Oncol; 2020 Sep; 6(9):1355-1362. PubMed ID: 32701140
[TBL] [Abstract][Full Text] [Related]
4. Integration of Genomic Profiling and Organoid Development in Precision Oncology.
Yoon H; Lee S
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008642
[TBL] [Abstract][Full Text] [Related]
5. Clinical trials in the era of personalized oncology.
Maitland ML; Schilsky RL
CA Cancer J Clin; 2011; 61(6):365-81. PubMed ID: 22034206
[TBL] [Abstract][Full Text] [Related]
6. Precision surgery and avoiding over-treatment.
Hosseini A; Khoury AL; Esserman LJ
Eur J Surg Oncol; 2017 May; 43(5):938-943. PubMed ID: 28238520
[TBL] [Abstract][Full Text] [Related]
7. Tailoring antiHer2 treatment strategies in breast cancer and beyond.
Fedele P; Sanna V; Santoro AN; Iaia ML; Fancellu A
Curr Probl Cancer; 2022 Oct; 46(5):100892. PubMed ID: 36055059
[TBL] [Abstract][Full Text] [Related]
8. Racial and Ethnic Disparities Among Participants in Precision Oncology Clinical Studies.
Aldrighetti CM; Niemierko A; Van Allen E; Willers H; Kamran SC
JAMA Netw Open; 2021 Nov; 4(11):e2133205. PubMed ID: 34748007
[TBL] [Abstract][Full Text] [Related]
9. Precision oncology for breast cancer through clinical trials.
Blucher AS; Mills GB; Tsang YH
Clin Exp Metastasis; 2022 Feb; 39(1):71-78. PubMed ID: 33950412
[TBL] [Abstract][Full Text] [Related]
10. The impact of race and ethnicity in breast cancer-disparities and implications for precision oncology.
Hirko KA; Rocque G; Reasor E; Taye A; Daly A; Cutress RI; Copson ER; Lee DW; Lee KH; Im SA; Park YH
BMC Med; 2022 Feb; 20(1):72. PubMed ID: 35151316
[TBL] [Abstract][Full Text] [Related]
11. Precision medicine in breast cancer.
Naito Y; Urasaki T
Chin Clin Oncol; 2018 Jun; 7(3):29. PubMed ID: 30056731
[TBL] [Abstract][Full Text] [Related]
12. COGNITION: a prospective precision oncology trial for patients with early breast cancer at high risk following neoadjuvant chemotherapy.
Pixberg C; Zapatka M; Hlevnjak M; Benedetto S; Suppelna JP; Heil J; Smetanay K; Michel L; Fremd C; Körber V; Rübsam M; Buschhorn L; Heublein S; Schäfgen B; Golatta M; Gomez C; von Au A; Wallwiener M; Wolf S; Dikow N; Schaaf C; Gutjahr E; Allgäuer M; Stenzinger A; Pfütze K; Kirsten R; Hübschmann D; Sinn HP; Jäger D; Trumpp A; Schlenk R; Höfer T; Thewes V; Schneeweiss A; Lichter P
ESMO Open; 2022 Dec; 7(6):100637. PubMed ID: 36423362
[TBL] [Abstract][Full Text] [Related]
13. Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment.
Schmidt KT; Chau CH; Price DK; Figg WD
J Clin Pharmacol; 2016 Dec; 56(12):1484-1499. PubMed ID: 27197880
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial.
Symmans WF; Yau C; Chen YY; Balassanian R; Klein ME; Pusztai L; Nanda R; Parker BA; Datnow B; Krings G; Wei S; Feldman MD; Duan X; Chen B; Sattar H; Khazai L; Zeck JC; Sams S; Mhawech-Fauceglia P; Rendi M; Sahoo S; Ocal IT; Fan F; LeBeau LG; Vinh T; Troxell ML; Chien AJ; Wallace AM; Forero-Torres A; Ellis E; Albain KS; Murthy RK; Boughey JC; Liu MC; Haley BB; Elias AD; Clark AS; Kemmer K; Isaacs C; Lang JE; Han HS; Edmiston K; Viscusi RK; Northfelt DW; Khan QJ; Leyland-Jones B; Venters SJ; Shad S; Matthews JB; Asare SM; Buxton M; Asare AL; Rugo HS; Schwab RB; Helsten T; Hylton NM; van 't Veer L; Perlmutter J; DeMichele AM; Yee D; Berry DA; Esserman LJ
JAMA Oncol; 2021 Nov; 7(11):1654-1663. PubMed ID: 34529000
[TBL] [Abstract][Full Text] [Related]
15. PET-Based Personalized Management in Clinical Oncology: An Unavoidable Path for the Foreseeable Future.
Basu S; Alavi A
PET Clin; 2016 Jul; 11(3):203-7. PubMed ID: 27321025
[TBL] [Abstract][Full Text] [Related]
16. Current updates on precision therapy for breast cancer associated brain metastasis: Emphasis on combination therapy.
Raza M; Kumar N; Nair U; Luthra G; Bhattacharyya U; Jayasundar S; Jayasundar R; Sehrawat S
Mol Cell Biochem; 2021 Sep; 476(9):3271-3284. PubMed ID: 33886058
[TBL] [Abstract][Full Text] [Related]
17. Towards personalized treatment for early stage HER2-positive breast cancer.
Goutsouliak K; Veeraraghavan J; Sethunath V; De Angelis C; Osborne CK; Rimawi MF; Schiff R
Nat Rev Clin Oncol; 2020 Apr; 17(4):233-250. PubMed ID: 31836877
[TBL] [Abstract][Full Text] [Related]
18. Obstacles to precision oncology: confronting current factors affecting the successful introduction of biomarkers to the clinic.
Prudkin L; Nuciforo P
Cell Oncol (Dordr); 2015 Feb; 38(1):39-48. PubMed ID: 25185990
[TBL] [Abstract][Full Text] [Related]
19. Clinical benefits of precision medicine in treating solid cancers: European Society of Medical Oncology-Magnitude of Clinical Benefit Scale score-based analysis.
Hibino Y; Ito M; Satake T; Kondo S
ESMO Open; 2021 Aug; 6(4):100187. PubMed ID: 34118770
[TBL] [Abstract][Full Text] [Related]
20. Insights into the theranostic value of precision medicine on advanced radiotherapy to breast cancer.
Jiang M; Yang J; Li K; Liu J; Jing X; Tang M
Int J Med Sci; 2021; 18(3):626-638. PubMed ID: 33437197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
